SELLAS Life Sciences Group, Inc. Fair Value Adjustment of Warrants
SELLAS Life Sciences Group, Inc. (SLS) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-03-20
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for the quarter ending 2024-12-31 was $0.00.
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for the quarter ending 2024-09-30 was $0.00.
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for the quarter ending 2024-06-30 was $0.00.
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for the quarter ending 2024-03-31 was $0.00.
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for fiscal 2024 was $0.00.
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for fiscal 2023 was -$4.00K.
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for fiscal 2022 was -$36.00K.
- SELLAS Life Sciences Group, Inc. fair value adjustment of warrants for fiscal 2021 was -$15.00K, a 115.46% decline from fiscal 2020.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | -$2.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | -$2.00K derived: sum of 3 quarters · filed 2025-03-20 | -$4.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | -$2.00K derived: sum of 2 quarters · filed 2024-11-13 | -$4.00K 10-Q · filed 2024-11-13 | -$1.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$2.00K 10-Q · filed 2024-08-13 | -$4.00K 10-Q · filed 2024-08-13 | -$1.00K derived: sum of 3 quarters · filed 2024-08-13 | -$3.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$2.00K 10-Q · filed 2024-05-14 | $1.00K derived: sum of 2 quarters · filed 2024-05-14 | -$1.00K derived: sum of 3 quarters · filed 2024-05-14 | -$49.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.00K derived: sum of 2 quarters · filed 2024-03-28 | -$47.00K derived: sum of 3 quarters · filed 2024-03-28 | -$36.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$2.00K 10-Q · filed 2023-11-09 | -$50.00K derived: sum of 2 quarters · filed 2023-11-09 | -$39.00K 10-Q · filed 2023-11-09 | -$83.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$48.00K 10-Q · filed 2023-08-10 | -$37.00K 10-Q · filed 2023-08-10 | -$81.00K derived: sum of 3 quarters · filed 2023-08-10 | -$111.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $11.00K 10-Q · filed 2023-05-11 | -$33.00K derived: sum of 2 quarters · filed 2023-05-11 | -$63.00K derived: sum of 3 quarters · filed 2023-05-11 | -$35.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$74.00K derived: sum of 2 quarters · filed 2023-03-16 | -$46.00K derived: sum of 3 quarters · filed 2023-03-16 | -$15.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$30.00K 10-Q · filed 2022-11-14 | -$2.00K derived: sum of 2 quarters · filed 2022-11-14 | $29.00K 10-Q · filed 2022-11-14 | $151.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $28.00K 10-Q · filed 2022-08-11 | $59.00K 10-Q · filed 2022-08-11 | $181.00K derived: sum of 3 quarters · filed 2022-08-11 | $175.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $31.00K 10-Q · filed 2022-05-12 | $153.00K derived: sum of 2 quarters · filed 2022-05-12 | $147.00K derived: sum of 3 quarters · filed 2022-05-12 | $163.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $116.00K derived: sum of 2 quarters · filed 2022-03-31 | $132.00K derived: sum of 3 quarters · filed 2022-03-31 | $97.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | -$6.00K 10-Q · filed 2021-11-12 | $10.00K derived: sum of 2 quarters · filed 2021-11-12 | -$25.00K 10-Q · filed 2021-11-12 | -$53.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $16.00K 10-Q · filed 2021-08-12 | -$19.00K 10-Q · filed 2021-08-12 | -$47.00K derived: sum of 3 quarters · filed 2021-08-12 | $2.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$35.00K 10-Q · filed 2021-05-13 | -$63.00K derived: sum of 2 quarters · filed 2021-05-13 | -$14.00K derived: sum of 3 quarters · filed 2021-05-13 | -$976.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $21.00K derived: sum of 2 quarters · filed 2021-03-23 | -$941.00K derived: sum of 3 quarters · filed 2021-03-23 | -$1.14M 10-K · filed 2021-03-23 |
| 2019-09-30 | $49.00K 10-Q · filed 2020-11-13 | -$913.00K derived: sum of 2 quarters · filed 2020-11-13 | -$1.11M 10-Q · filed 2020-11-13 | -$1.07M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$962.00K 10-Q · filed 2020-08-13 | -$1.16M 10-Q · filed 2020-08-13 | -$1.12M derived: sum of 3 quarters · filed 2020-08-13 | -$3.36M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$195.00K 10-Q · filed 2020-05-14 | -$155.00K derived: sum of 2 quarters · filed 2020-05-14 | -$2.40M derived: sum of 3 quarters · filed 2020-05-14 | -$3.61M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$2.20M derived: sum of 2 quarters · filed 2020-03-13 | -$3.42M derived: sum of 3 quarters · filed 2020-03-13 | -$5.30M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$2.24M 10-Q · filed 2019-11-14 | -$3.46M derived: sum of 2 quarters · filed 2019-11-14 | -$5.34M 10-Q · filed 2019-11-14 | -$5.34M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$1.22M 10-Q · filed 2019-08-14 | -$3.10M 10-Q · filed 2019-08-14 | -$3.10M derived: sum of 3 quarters · filed 2019-08-14 | -$3.10M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$1.88M 10-Q · filed 2019-05-15 | -$1.88M derived: sum of 2 quarters · filed 2019-05-15 | -$1.88M derived: sum of 3 quarters · filed 2019-05-15 | -$1.88M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $0.00 derived: sum of 2 quarters · filed 2019-03-22 | $0.00 derived: sum of 3 quarters · filed 2019-03-22 | $0.00 10-K · filed 2019-03-22 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |